SHJ
MDCO

Sharkey, Howes & Javer’s Medicines Co MDCO Stock Holding History

Sharkey, Howes & Javer’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-458
Closed -$15K – 265
2016
Q1 		$15K Buy
+458
New +$15K 0.01% 166

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sharkey, Howes & Javer's MDCO Position: Q2 2016 in Review

Sharkey, Howes & Javer sold out of Medicines Co (MDCO) in Q2 2016, closing a stake of 458 shares — an estimated $15K sold.

Sharkey, Howes & Javer first reported a position in MDCO in Q1 2016 and held it in 1 quarter. The position peaked at $15K in Q1 2016. 190 funds tracked by Wall St. Rank hold MDCO as of Q2 2016.

  • Sharkey, Howes & Javer reported no remaining Medicines Co position as of Q2 2016 after selling out during the quarter.
  • Sharkey, Howes & Javer sold 458 Medicines Co shares in Q2 2016, an estimated $15K.
  • Sharkey, Howes & Javer first reported a position in Medicines Co in Q1 2016 and held it in 1 quarter.
  • Sharkey, Howes & Javer's Medicines Co position peaked at $15K in Q1 2016.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q2 2016.

Based on Sharkey, Howes & Javer's 13F filing for Q2 2016, filed 5 Aug 2016.